CMAJ:宝宝不怕!使用麻醉霜可有效减轻疫苗接种时的疼痛

2016-12-15 MedSci MedSci原创

接种疫苗会引起婴儿急性疼痛和痛苦,会导致家长对婴儿疫苗接种的不满和迟疑。为了比较出生第一年婴儿接种疫苗时使用疼痛干预措施的有效性,研究人员设计了一个多中心、纵向、双盲、附加、随机对照试验。根据在2,4,6,12个月接受疫苗接种时的疼痛管理将健康婴儿随机分为四组:(i)安慰剂对照(ii) 关于婴儿安抚的家长视频教育(iii)视频加口服蔗糖 (iv)视频加口服蔗糖加局部应用利多卡因脂质体。使用双模拟设

接种疫苗会引起婴儿急性疼痛和痛苦,会导致家长对婴儿疫苗接种的不满和迟疑。为了比较出生第一年婴儿接种疫苗时使用疼痛干预措施的有效性,研究人员设计了一个多中心、纵向、双盲、附加、随机对照试验。

根据在2,4,6,12个月接受疫苗接种时的疼痛管理将健康婴儿随机分为四组:(i)安慰剂对照(ii) 关于婴儿安抚的家长视频教育(iii)视频加口服蔗糖 (iv)视频加口服蔗糖加局部应用利多卡因脂质体。使用双模拟设计,所有家长观看视频(积极的心理干预或安慰),所有婴儿接受口服制剂(蔗糖或安慰剂)和外用乳膏(利多卡因或安慰剂)。在这三个阶段—注射前(基线),注射疫苗(注射时)和注射后1分钟(恢复)使用改良行为疼痛量表(0-10级)来评估婴儿的痛苦。使用混合模型重复测量分析法比较组别和年龄的分值。

研究共纳入352名婴儿,出生日期从2012年1月17日到2016年2月2日。所有研究对象人口特征在各干预组没有差别。

结果发现,各组的基线疼痛值没有差别(p = 0.4),年龄之间有差别(p < 0.001)。注射时疼痛值在组间和年龄上均有差别(p = 0.003 和p < 0.001)。比较注射时均值(±标准差),视频-蔗糖-利多卡因组是6.3(±0.8),其余各组是6.7(±0.8)。没有其他组间差异。恢复值在组间没有差别(p = 0.98),在年龄中有差别(p < 0.001)。

总而言之,研究发现仅有接受了麻醉膏管理的婴儿在疫苗接种时疼痛大大缓解,此外,他们还发现,6月龄以下时婴儿对疼痛的反应下降,而6-12月龄时婴儿对疼痛的反应又开始增加。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1257829, encodeId=164a125e82959, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Dec 17 03:47:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163336, encodeId=697a1633363e, content=有点意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Dec 16 20:39:08 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163069, encodeId=5119163069aa, content=大人也怕疼的, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 15 16:58:24 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249742, encodeId=98901249e429b, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Thu Dec 15 15:47:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163056, encodeId=c5cd1630565d, content=有待进一步循证支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Dec 15 15:23:20 CST 2016, time=2016-12-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1257829, encodeId=164a125e82959, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Dec 17 03:47:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163336, encodeId=697a1633363e, content=有点意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Dec 16 20:39:08 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163069, encodeId=5119163069aa, content=大人也怕疼的, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 15 16:58:24 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249742, encodeId=98901249e429b, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Thu Dec 15 15:47:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163056, encodeId=c5cd1630565d, content=有待进一步循证支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Dec 15 15:23:20 CST 2016, time=2016-12-15, status=1, ipAttribution=)]
    2016-12-16 smartxiuxiu

    有点意思

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1257829, encodeId=164a125e82959, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Dec 17 03:47:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163336, encodeId=697a1633363e, content=有点意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Dec 16 20:39:08 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163069, encodeId=5119163069aa, content=大人也怕疼的, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 15 16:58:24 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249742, encodeId=98901249e429b, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Thu Dec 15 15:47:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163056, encodeId=c5cd1630565d, content=有待进一步循证支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Dec 15 15:23:20 CST 2016, time=2016-12-15, status=1, ipAttribution=)]
    2016-12-15 xiaotaiyang1

    大人也怕疼的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1257829, encodeId=164a125e82959, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Dec 17 03:47:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163336, encodeId=697a1633363e, content=有点意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Dec 16 20:39:08 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163069, encodeId=5119163069aa, content=大人也怕疼的, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 15 16:58:24 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249742, encodeId=98901249e429b, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Thu Dec 15 15:47:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163056, encodeId=c5cd1630565d, content=有待进一步循证支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Dec 15 15:23:20 CST 2016, time=2016-12-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1257829, encodeId=164a125e82959, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Dec 17 03:47:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163336, encodeId=697a1633363e, content=有点意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri Dec 16 20:39:08 CST 2016, time=2016-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163069, encodeId=5119163069aa, content=大人也怕疼的, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 15 16:58:24 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249742, encodeId=98901249e429b, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Thu Dec 15 15:47:00 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163056, encodeId=c5cd1630565d, content=有待进一步循证支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Dec 15 15:23:20 CST 2016, time=2016-12-15, status=1, ipAttribution=)]
    2016-12-15 dhzzm

    有待进一步循证支持

    0

相关资讯

特朗普竞选期间曾与反疫苗积极分子见面

唐纳德·特朗普 图片来源:Gage Skidmore/Flickr 2016年8月,美国共和党总统提名者唐纳德·特朗普曾与将疫苗和孤独症联系在一起的著名的反疫苗支持者谈话,其中包括被取消资格的英国内科医生、佛罗里达州资金筹集人Andrew Wakefield。 特朗普曾与一群捐助者聊了45分钟,其中包括4名反对疫苗接种的积极分子,根据会议记录,他还承诺将观看Va

Science:北大教授找到可能应对几乎所有病毒的疫苗制备方法

北京大学的研究者找到了一种快速制备病毒疫苗的方法,适用于几乎所有病毒。  近日,《科学》(Science)刊登了北京大学药学院周德敏教授和张礼和院士团队的一项研究。他们研制出了具有完整病毒结构,并能快速制备的活病毒疫苗,该成果或将普遍适用于几乎所有病毒,因此有可能成为病毒疫苗领域的革命性突破。本文通讯作者周德敏教授接受《环球科学》记者的采访,向我们详细讲解了这项研究。&nb

Lancet Neurol:科学家有望开发出治疗阿尔兹海默病的疫苗

图片摘自:ehow-blog.com 截止到目前为止,很多用于治疗阿尔兹海默病的抗体药物仅仅能够靶向作用患者机体中淀粉样斑块,尽管最新的临床试验被认为能够更好地开发出治疗阿尔兹海默病的新型疗法,但因为会引发缓和出现严重的副作用,比如大脑中炎症和流体异常的积累,最后该临床试验在晚期阶段宣告失败,研究者推测引发副作用的原因或许就因为治疗性抗体或许会诱发血管中正常淀粉样蛋白的反应,或者会在患者血管

Retrovirology:灭活的全HIV疫苗SAV001可引发抗HIV免疫应答,安全性良好

灭活的全HIV疫苗SAV001可引发抗HIV免疫应答,而且十分安全,但这种免疫应答是否预防HIV感染仍需进一步探索。

JAMA Pediatrics:孕期是否接受流感疫苗接种与其后代自闭症的发生之间并无关联

既往一些研究表明,怀孕期间感染流感病毒可能会提高孩子患自闭症的风险。然而,近日来自奥克兰的北加州凯瑟医疗中心的一项新的大规模的研究则发现结果并非如此,其研究结果已发表于JAMA Pediatrics。研究纳入了2000-2010年间的196929次生育,包括1400名患有流感的母亲和45231名在怀孕期间接受流感疫苗接种的母亲。所纳入的婴儿中,3101名(1.6%)被诊断为ASD。这项研究并没有发